Emcure Pharmaceuticals Ltd.

EMCURE

₹1453.5

-0.09% (-1.3)

Market Cap

₹27,566 Cr.

P/E

37.04

About

Emcure Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and global marketing of a wide range of pharmaceutical products across various thera… Read more

Emcure Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the develo… Read more

Low

889

52W Range

High

1580

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Share price

Share price has decreased over last 10 years more due to earnings
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Formulation

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Acute vs Chronic

Asset Break-Up - Geography Wise

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
US DMF Filings (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Emcure Pharmaceuticals Ltd. Business

What does Emcure Pharma do?

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.

Who are the competitors of Emcure Pharma?

Emcure Pharma major competitors are JB Chem & Pharma, Piramal Pharma, Wockhardt, Pfizer, Eris Lifesciences, Gland Pharma, Ajanta Pharma.
Market Cap of Emcure Pharma is ₹27,566 Crs.
While the median market cap of its peers are ₹25,256 Crs.

Is Emcure Pharma financially stable compared to its competitors?

Emcure Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Emcure Pharma is 6.89 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Sep Dec
Investor Presentation
Conference Call	Mar Jun	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

About

Timeline

Company Timeline

8 Yes

1 Neutral

7 No

1 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Depreciation Effect

Promoter Holding

Retail Holding

Revenue Recognition

Price & Performance

ROE

Debt

ROCE Strength

Balance Sheet Strength

Share price

Capex vs ROCE

Current vs Historic Valuation

Working Capital

Margin Stability

Sales Growth

Product Wise Break-Up

UNLOCK PREMIUM

Product Wise Break-Up - Formulation

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Acute vs Chronic

UNLOCK PREMIUM

Asset Break-Up - Geography Wise

UNLOCK PREMIUM

What does Emcure Pharma do?

Who are the competitors of Emcure Pharma?

Is Emcure Pharma financially stable compared to its competitors?

SIGN UP FOR FREE